Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SkyePharma PLC (OTC Pink - Current Information:SKYEY)

6.71
Delayed Data
As of May 24
 0.00 / 0.00%
Today’s Change
3.95
Today|||52-Week Range
6.97
+13.54%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues79.5M98.0M121.5M146.3M
 
 
 
 
 
Cost of Goods Sold29.6M46.7M49.9M62.8M
 
 
 
 
 
Depreciation And Amortization4.8M6.7M5.6M4.3M
 
 
 
 
 
 
Operating ExpensesGross Income45.1M44.6M66.0M79.2M
 
 
 
 
 
General Expenses26.1M24.0M29.0M32.3M
 
 
 
 
 
Research And Development20.5M16.9M19.9M22.7M
 
 
 
 
 
Total Operating Expenses60.5M77.4M84.5M99.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income19.0M20.7M37.0M46.8M
 
 
 
 
 
Extraordinary Credit8.0M--658.6K305.1K
 
 
 
 
Extraordinary Charge-26.4M-156.6K-43.8M0.00
 
 
 
 
Interest Expense On Debt18.8M22.1M10.7M2.0M
 
 
 
 
 
Other Expenses1.8M-156.6K329.3K1.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-16.6M-1.6M-16.3M46.5M
 
 
 
 
 
Income Taxes-318.6K-2.8M-987.9K-6.4M
 
 
 
 
 
Discontinued Operations9.9M0.000.000.00
 
 
Net Income-7.0M1.3M-17.3M40.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS33.2M51.9M85.3M104.8M
 
 
 
 
 
Shares To Calculate EPS Diluted33.2M53.7M85.3M107.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.21$0.03-$0.20$0.38
 
 
 
 
 
EPS Diluted-$0.21$0.02-$0.20$0.38